Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 5
2004 7
2005 2
2006 2
2007 6
2008 6
2009 5
2010 7
2011 12
2012 9
2013 6
2014 12
2015 10
2016 13
2017 16
2018 15
2019 11
2020 10
2021 5
2022 12
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond.
Pandey S, Cholak ME, Yadali R, Sosman JA, Tetreault MP, Fang D, Pollack SM, Gnjatic S, Obeng RC, Lyerly HK, Sonabend AM, Guevara-Patiño JA, Butterfield LH, Zhang B, Maecker HT, Le Poole IC. Pandey S, et al. Among authors: butterfield lh. Cancers (Basel). 2024 Jan 23;16(3):475. doi: 10.3390/cancers16030475. Cancers (Basel). 2024. PMID: 38339227 Free PMC article.
Publisher Correction: Advancing T cell-based cancer therapy with single-cell technologies.
Bucktrout SL, Banovich NE, Butterfield LH, Cimen-Bozkus C, Giles JR, Good Z, Goodman D, Jonsson VD, Lareau C, Marson A, Maurer DM, Munson PV, Stubbington M, Taylor S, Cutchin A. Bucktrout SL, et al. Among authors: butterfield lh. Nat Med. 2024 Feb 5. doi: 10.1038/s41591-024-02841-x. Online ahead of print. Nat Med. 2024. PMID: 38317023 No abstract available.
Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases.
Wilmott JS, Tawbi H, Engh JA, Amankulor NM, Shivalingam B, Banerjee H, Vergara IA, Lee H, Johansson PA, Ferguson PM, Saiag P, Robert C, Grob JJ, Butterfield LH, Scolyer RA, Kirkwood JM, Long GV, Davies MA. Wilmott JS, et al. Among authors: butterfield lh. Clin Cancer Res. 2023 Feb 1;29(3):521-531. doi: 10.1158/1078-0432.CCR-22-2581. Clin Cancer Res. 2023. PMID: 36477181 Free PMC article. Clinical Trial.
What's next for cancer vaccines.
Adamik J, Butterfield LH. Adamik J, et al. Among authors: butterfield lh. Sci Transl Med. 2022 Nov 9;14(670):eabo4632. doi: 10.1126/scitranslmed.abo4632. Epub 2022 Nov 9. Sci Transl Med. 2022. PMID: 36350992 Review.
Advancing T cell-based cancer therapy with single-cell technologies.
Bucktrout SL, Banovich NE, Butterfield LH, Cimen-Bozkus C, Giles JR, Good Z, Goodman D, Jonsson VD, Lareau C, Marson A, Maurer DM, Munson PV, Stubbington M, Taylor S, Cutchin A. Bucktrout SL, et al. Among authors: butterfield lh. Nat Med. 2022 Sep;28(9):1761-1764. doi: 10.1038/s41591-022-01986-x. Nat Med. 2022. PMID: 36127419 No abstract available.
171 results